DK1630232T3 - Optimerede nukleotidsekvenser kodende for sgp130 - Google Patents
Optimerede nukleotidsekvenser kodende for sgp130Info
- Publication number
- DK1630232T3 DK1630232T3 DK04020455T DK04020455T DK1630232T3 DK 1630232 T3 DK1630232 T3 DK 1630232T3 DK 04020455 T DK04020455 T DK 04020455T DK 04020455 T DK04020455 T DK 04020455T DK 1630232 T3 DK1630232 T3 DK 1630232T3
- Authority
- DK
- Denmark
- Prior art keywords
- sgp130
- nucleotide sequences
- sequences encoding
- optimized nucleotide
- encoding sgp130
- Prior art date
Links
- 102000005754 Cytokine Receptor gp130 Human genes 0.000 title abstract 3
- 108010006197 Cytokine Receptor gp130 Proteins 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108020004705 Codon Proteins 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04020455A EP1630232B1 (en) | 2004-08-27 | 2004-08-27 | Optimized nucleotide sequences encoding sgp130 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1630232T3 true DK1630232T3 (da) | 2008-10-20 |
Family
ID=34926337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04020455T DK1630232T3 (da) | 2004-08-27 | 2004-08-27 | Optimerede nukleotidsekvenser kodende for sgp130 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8206948B2 (da) |
| EP (2) | EP1630232B1 (da) |
| JP (1) | JP4615016B2 (da) |
| AT (1) | ATE399868T1 (da) |
| AU (1) | AU2005276581A1 (da) |
| CA (1) | CA2575800C (da) |
| DE (1) | DE602004014758D1 (da) |
| DK (1) | DK1630232T3 (da) |
| ES (1) | ES2309427T3 (da) |
| PT (1) | PT1630232E (da) |
| WO (1) | WO2006021453A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006016765D1 (de) | 2006-06-30 | 2010-10-21 | Conaris Res Inst Ag | Verbesserte sgp 130Fc Dimere |
| PT3227325T (pt) * | 2014-12-01 | 2024-07-01 | Ferring Bv | Composições inibidoras seletivas da sinalização trans de il-6 |
| MD3226888T2 (ro) | 2014-12-01 | 2021-08-31 | Ferring Bv | Administrarea unui inhibitor de trans-semnalizare a IL-6 selectiv |
| GB201522186D0 (en) | 2015-12-16 | 2016-01-27 | Singapore Health Services Pte Ltd And Nat University Of Singapore The | Treatment of fibrosis |
| KR20190096390A (ko) | 2016-12-16 | 2019-08-19 | 싱가포르 헬스 서비시즈 피티이 엘티디 | Il-11 항체 |
| GB201621431D0 (en) * | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore The | Decoy cytokine receptor |
| GB201621439D0 (en) | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore | IL-11Ra Antibodies |
| KR20210138579A (ko) | 2019-01-21 | 2021-11-19 | 싱가포르 헬스 서비시즈 피티이 엘티디 | 간독성의 치료 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5783672A (en) * | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| DE60037648T2 (de) * | 2000-04-21 | 2010-06-17 | Conaris Research Institute Ag | Fusionsproteine, die zwei lösliche gp130 Moleküle enthalten |
| JP2004182638A (ja) * | 2002-12-03 | 2004-07-02 | Yakult Honsha Co Ltd | 炎症性疾患又は悪性腫瘍の予防治療剤 |
| EP1491554A1 (en) * | 2003-06-23 | 2004-12-29 | CONARIS research institute AG | PEGylated soluble gp130-dimers useful as a medicament |
-
2004
- 2004-08-27 EP EP04020455A patent/EP1630232B1/en not_active Expired - Lifetime
- 2004-08-27 DK DK04020455T patent/DK1630232T3/da active
- 2004-08-27 AT AT04020455T patent/ATE399868T1/de active
- 2004-08-27 ES ES04020455T patent/ES2309427T3/es not_active Expired - Lifetime
- 2004-08-27 PT PT04020455T patent/PT1630232E/pt unknown
- 2004-08-27 DE DE602004014758T patent/DE602004014758D1/de not_active Expired - Lifetime
-
2005
- 2005-08-26 EP EP05776083A patent/EP1791960A2/en not_active Withdrawn
- 2005-08-26 AU AU2005276581A patent/AU2005276581A1/en not_active Abandoned
- 2005-08-26 CA CA2575800A patent/CA2575800C/en not_active Expired - Lifetime
- 2005-08-26 US US11/660,461 patent/US8206948B2/en active Active
- 2005-08-26 JP JP2007528753A patent/JP4615016B2/ja not_active Expired - Lifetime
- 2005-08-26 WO PCT/EP2005/009247 patent/WO2006021453A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT1630232E (pt) | 2008-10-02 |
| JP2008510474A (ja) | 2008-04-10 |
| ES2309427T3 (es) | 2008-12-16 |
| US8206948B2 (en) | 2012-06-26 |
| CA2575800A1 (en) | 2006-03-02 |
| ATE399868T1 (de) | 2008-07-15 |
| WO2006021453A3 (en) | 2006-06-22 |
| EP1630232A1 (en) | 2006-03-01 |
| JP4615016B2 (ja) | 2011-01-19 |
| AU2005276581A1 (en) | 2006-03-02 |
| EP1791960A2 (en) | 2007-06-06 |
| EP1630232B1 (en) | 2008-07-02 |
| WO2006021453A2 (en) | 2006-03-02 |
| US20080199906A1 (en) | 2008-08-21 |
| CA2575800C (en) | 2018-06-05 |
| DE602004014758D1 (de) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE530643T1 (de) | Säureaktive fungale protease | |
| DK1622921T3 (da) | Varianter af beta-glucosidaser | |
| ATE491788T1 (de) | Proteasevarianten | |
| ATE500337T1 (de) | Verfahren zur durchführung homologer rekombinationen in pflanzen | |
| CO6341638A2 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
| ATE491794T1 (de) | Zusammensetzung und verfahren zur herstellung von steviolglykosiden | |
| EP2295555A3 (en) | Polypeptides having lipase activity and polynucleotides encodig same | |
| ATE469971T1 (de) | Mikroorganismen als träger von für antigene und proteintoxine codierende nukleotidsequenzen, verfahren zur herstellung und verwendungen davon | |
| EA201001881A1 (ru) | Пролинспецифичная протеаза из penicillium chrysogenum | |
| ATE491809T1 (de) | Amplifikation von dna-fragmenten | |
| SG156690A1 (en) | Mammalian genes involved in infection | |
| DK2152732T3 (da) | Modificeret sekretionssystem til at øge ekspression af polypeptider i bakterier | |
| DK1630232T3 (da) | Optimerede nukleotidsekvenser kodende for sgp130 | |
| GB2439039A (en) | Identification of a sterol acyltransferase gene | |
| ATE533837T1 (de) | Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen | |
| ATE539163T1 (de) | Auf der verwendung von mva beruhende impfstoffe | |
| EP2067857A4 (en) | PROCESS FOR DIPEPTIDE PRODUCTION | |
| WO2006076628A3 (en) | Compositions comprising promoter sequences and methods of use | |
| AU2002346803A1 (en) | Genes encoding for carbon metabolism and energy-producing proteins | |
| DE602006010990D1 (de) | Verfahren zur dipeptidherstellung | |
| DE60326716D1 (de) | Promoter Sequenzen aus Moos und dessen Verwendung | |
| ATE420950T1 (de) | Verfahren zur herstellung von lipasen | |
| ATE430191T1 (de) | Überexprimierte und gereinigte aspergillus ficuum oxidase und nukleinsäuren die für sie kodieren | |
| DK1866437T3 (da) | Fremgangsmåde til at screene for tilstedeværelsen af en genetisk defekt associeret med dyb venøs thrombose | |
| BR0114719A (pt) | Moléculas de aggrecanase |